Coronary artery revascularization in patients with diabetes mellitus.
作者信息
Armstrong Ehrin J, Rutledge John C, Rogers Jason H
机构信息
University of California, Davis Medical Center, Division of Cardiovascular Medicine, Sacramento.
出版信息
Circulation. 2013 Oct 8;128(15):1675-85. doi: 10.1161/CIRCULATIONAHA.113.002114.
Abstract
摘要
相似文献
1
Coronary artery revascularization in patients with diabetes mellitus.糖尿病患者的冠状动脉血运重建
Circulation. 2013 Oct 8;128(15):1675-85. doi: 10.1161/CIRCULATIONAHA.113.002114.
2
Coronary revascularisation in the patient with diabetes: balancing risk and benefit.糖尿病患者的冠状动脉血运重建：权衡风险与获益
Heart. 2010 Sep;96(18):1436-40. doi: 10.1136/hrt.2010.201541.
3
Percutaneous coronary intervention in diabetics: time to consider "intimal remodelling therapy"?糖尿病患者的经皮冠状动脉介入治疗：是时候考虑“内膜重塑疗法”了吗？
Heart. 2002 Sep;88(3):213-5. doi: 10.1136/heart.88.3.213.
4
Strategies for multivessel revascularization in patients with diabetes.多血管血运重建策略在糖尿病患者中的应用。
J Comp Eff Res. 2013 May;2(3):231-4. doi: 10.2217/cer.13.21.
5
Everolimus Eluting Stents Versus Coronary Artery Bypass Graft Surgery for Patients With Diabetes Mellitus and Multivessel Disease.依维莫司洗脱支架与冠状动脉旁路移植术治疗糖尿病合并多支血管病变患者的疗效比较
Circ Cardiovasc Interv. 2015 Jul;8(7):e002626. doi: 10.1161/CIRCINTERVENTIONS.115.002626.
6
[Percutaneous coronary intervention in patients with diabetes].[糖尿病患者的经皮冠状动脉介入治疗]
Dtsch Med Wochenschr. 2002 Mar 29;127(13):689-94. doi: 10.1055/s-2002-23484.
7
Effect of diabetes mellitus on outcome after percutaneous transluminal coronary angioplasty.糖尿病对经皮腔内冠状动脉成形术后结局的影响。
J Cardiovasc Risk. 1997 Apr;4(2):112-20.
8
Clinical studies on coronary revascularization in patients with type 2 diabetes.2型糖尿病患者冠状动脉血运重建的临床研究。
Eur Heart J. 2003 Jun;24(12):1087-103. doi: 10.1016/s0195-668x(03)00111-8.
9
Coronary revascularization in the diabetic patient.糖尿病患者的冠状动脉血运重建
Circulation. 2014 Sep 9;130(11):918-22. doi: 10.1161/CIRCULATIONAHA.113.004382.
10
[Percutaneous coronary interventions in diabetic patients].[糖尿病患者的经皮冠状动脉介入治疗]
Vnitr Lek. 2010 Apr;56(4):320-3.
引用本文的文献
1
Myocardial Revascularization in Patients with Diabetes and Heart Failure-A Narrative Review.糖尿病合并心力衰竭患者的心肌血运重建——一项叙述性综述
Int J Mol Sci. 2025 Apr 5;26(7):3398. doi: 10.3390/ijms26073398.
2
Glucose-Lowering Drugs with Proven Cardiovascular Benefit Following Acute Coronary Syndrome in Patients with Type 2 Diabetes: Treatment Gaps and Outcomes.2型糖尿病患者急性冠状动脉综合征后具有已证实心血管益处的降糖药物：治疗差距与结局
J Clin Med. 2024 Sep 19;13(18):5541. doi: 10.3390/jcm13185541.
3
Impact of systematic diabetes screening on peri-operative infections in patients undergoing cardiac surgery.心脏手术患者接受系统性糖尿病筛查对围手术期感染的影响。
Sci Rep. 2024 Jun 20;14(1):14182. doi: 10.1038/s41598-024-65064-7.
4
Cardiometabolic Risk Factors Associated With Type 2 Diabetes Mellitus: A Mechanistic Insight.与2型糖尿病相关的心血管代谢危险因素：机制洞察
Clin Med Insights Endocrinol Diabetes. 2023 Dec 25;16:11795514231220780. doi: 10.1177/11795514231220780. eCollection 2023.
5
Off-pump vs. on-pump bypass surgery grafting in diabetic patients with three-vessel disease: a propensity score matching study.非体外循环与体外循环搭桥手术在三支血管病变糖尿病患者中的血管移植：一项倾向评分匹配研究
Front Cardiovasc Med. 2023 Nov 30;10:1249881. doi: 10.3389/fcvm.2023.1249881. eCollection 2023.
6
Inflammatory Markers Used as Predictors of Subclinical Atherosclerosis in Patients with Diabetic Polyneuropathy.炎症标志物作为糖尿病性多发性神经病患者亚临床动脉粥样硬化的预测指标
Life (Basel). 2023 Sep 3;13(9):1861. doi: 10.3390/life13091861.
7
Diabetes mellitus-related hospital admissions and prescriptions of antidiabetic agents in England and Wales: an ecological study.英国和威尔士的糖尿病相关住院治疗和抗糖尿病药物处方：一项生态学研究。
BMC Endocr Disord. 2023 May 6;23(1):102. doi: 10.1186/s12902-023-01352-z.
8
Spatial Reorganization of Liquid Crystalline Domains of Red Blood Cells in Type 2 Diabetic Patients with Peripheral Artery Disease.2 型糖尿病合并外周动脉疾病患者红细胞液晶畴的空间重排。
Int J Mol Sci. 2022 Sep 22;23(19):11126. doi: 10.3390/ijms231911126.
9
The Impact of Hypoglycemic Therapy on the Prognosis for Acute Coronary Syndrome in Patients with Type 2 Diabetes.降糖治疗对2型糖尿病患者急性冠脉综合征预后的影响
J Pers Med. 2022 May 22;12(5):845. doi: 10.3390/jpm12050845.
10
Efficacy of Zotarolimus-Eluting Stents in Treating Diabetic Coronary Lesions: An Optical Coherence Tomography Study.载唑雷莫司洗脱支架治疗糖尿病冠状动脉病变的疗效：光学相干断层成像研究。
Adv Ther. 2020 Apr;37(4):1579-1590. doi: 10.1007/s12325-020-01273-6. Epub 2020 Mar 7.
本文引用的文献
1
Clinical outcome of patients with and without diabetes mellitus after percutaneous coronary intervention with the resolute zotarolimus-eluting stent: 2-year results from the prospectively pooled analysis of the international global RESOLUTE program.经皮冠状动脉介入治疗后伴或不伴糖尿病患者的临床结局：国际前瞻性 RESOLUTE 计划汇总分析的 2 年结果。
JACC Cardiovasc Interv. 2013 Apr;6(4):357-68. doi: 10.1016/j.jcin.2012.11.006. Epub 2013 Mar 20.
2
Risk factor control for coronary artery disease secondary prevention in large randomized trials.大型随机试验中冠心病二级预防的危险因素控制。
J Am Coll Cardiol. 2013 Apr 16;61(15):1607-15. doi: 10.1016/j.jacc.2013.01.044.
3
Metformin impairs vascular endothelial recovery after stent placement in the setting of locally eluted mammalian target of rapamycin inhibitors via S6 kinase-dependent inhibition of cell proliferation.二甲双胍通过 S6 激酶依赖性抑制细胞增殖来抑制局部洗脱哺乳动物雷帕霉素靶蛋白抑制剂后支架置入部位的血管内皮恢复。
J Am Coll Cardiol. 2013 Mar 5;61(9):971-80. doi: 10.1016/j.jacc.2012.12.018.
4
Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.冠状动脉旁路移植术与经皮冠状动脉介入治疗在三支病变合并左主干病变患者中的比较：随机、临床 SYNTAX 试验的 5 年随访结果。
Lancet. 2013 Feb 23;381(9867):629-38. doi: 10.1016/S0140-6736(13)60141-5.
5
Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.糖尿病患者复杂冠状动脉疾病的治疗：SYNTAX 试验比较旁路手术和经皮冠状动脉介入治疗 5 年结果。
Eur J Cardiothorac Surg. 2013 May;43(5):1006-13. doi: 10.1093/ejcts/ezt017. Epub 2013 Feb 14.
6
Prognostic impact of the presence and absence of angina on mortality and cardiovascular outcomes in patients with type 2 diabetes and stable coronary artery disease: results from the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trial.在 2 型糖尿病合并稳定型冠状动脉疾病患者中，有无心绞痛对死亡率和心血管结局的预后影响：来自 BARI 2D（旁路血管成形术血运重建调查 2 型糖尿病）试验的结果。
J Am Coll Cardiol. 2013 Feb 19;61(7):702-11. doi: 10.1016/j.jacc.2012.11.036.
7
Standards of medical care in diabetes--2013.《糖尿病医疗护理标准——2013》
Diabetes Care. 2013 Jan;36 Suppl 1(Suppl 1):S11-66. doi: 10.2337/dc13-S011.
8
ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design.ABSORB II 随机对照临床试验：比较 Absorb 依维莫司洗脱生物可吸收血管支架系统与 XIENCE 依维莫司洗脱冠状动脉支架系统治疗初发原生冠状动脉病变所致缺血性心脏病患者的安全性、疗效和性能的临床评估：原理和研究设计。
Am Heart J. 2012 Nov;164(5):654-63. doi: 10.1016/j.ahj.2012.08.010.
9
Strategies for multivessel revascularization in patients with diabetes.多血管血运重建策略在糖尿病患者中的应用。
N Engl J Med. 2012 Dec 20;367(25):2375-84. doi: 10.1056/NEJMoa1211585. Epub 2012 Nov 4.
10
Visual-functional mismatch between coronary angiography and fractional flow reserve.冠状动脉造影与血流储备分数之间的视觉-功能不匹配。
JACC Cardiovasc Interv. 2012 Oct;5(10):1029-36. doi: 10.1016/j.jcin.2012.07.007.
Zotero 插件